Unique hybrid implant first installed to a cat

Unique hybrid implant first installed to a cat
A domestic cat, "Lapunya" ("Sweetie" in English). Credit: Sergey Gnuskov/NUST MISIS

A scientific team from a small innovative enterprise, Biomimetix, based at the National University of Science and Technology MISIS together with their colleagues from the N.N. Blokhin National Medical Research Centre of oncology developed a unique implant to replace damaged bone fragments. The implant, which imitates real bone structure, was tested on a domestic cat with osteosarcoma by surgeons at the veterinary clinic "Biocontrol." According to postoperative observations, the implant fits well and the dynamics of recovery of the whiskered patient is positive.

Young scientists from a small innovative enterprise based on the National University of Science and Technology MISIS has been developing biocompatible bone implants based on ultrahigh molecular weight polyethylene (UHMWPE). The core of the hybrid is made of porous ultra-high molecular weight polyethylene, and the frame is made of a titanium alloy printed on a 3-D printer. Such a structure imitates the structure of real bone, where UHMWPE corresponds to the porous internal, trabecular part, and titanium alloy imitates the solid external, cortical part.

In March-April 2019 the therapy was implanted on a , "Lapunya" ("Sweetie" in English) after the removal of a 6 cm , damaged by osteosarcoma. In collaboration with N. Blokhin National Medical Research Centre of oncology a unique bone-cellular structure was developed: Biomimetix's specialists manufactured the implant, and their colleagues from the Laboratory of Cellular Immune Systems and doped it with cells extracted from the bone marrow of the cat, to shorten the adaptation period. The surgery was carried out by surgeons of the veterinary clinic "Biocontrol."

Unique hybrid implant first installed to a cat
Sterile titanium blanks for implants. Credit: Sergey Gnuskov/NUST MISIS

"Our implant almost completely corresponds to the usual bone. First of all, this means that it will not take on excessive load, so the at the place of its attachment will not become brittle, as it often happens with metal implants. In addition, the polymer surface of the implant is convenient to dope it with the patient's own cells, which significantly accelerates survival. This is especially important given the fact that we cannot explain to pets that at the time of recovery, the limb should be protected," says Fyodor Senatov, CEO of Biomimetix and researcher at NUST MISIS Center of Composite Materials.

According to the postoperative observations as of July 2019 the implant fits well, the dynamic of recovery is positive and the cat can walk normally. Thus, the use of such a hybrid cell-engineering implant seems a good alternative to the traditional radical treatment—amputation, as well as to much more complex metal implants.

Unique hybrid implant first installed to a cat
A domestic cat, "Lapunya." Credit: Sergey Gnuskov/NUST MISIS

Explore further

Scientists successfully implant a polymeric prosthesis imitating bone structure

Provided by National University of Science and Technology MISIS
Citation: Unique hybrid implant first installed to a cat (2019, July 22) retrieved 22 September 2019 from https://phys.org/news/2019-07-unique-hybrid-implant-cat.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
34 shares

Feedback to editors

User comments

Jul 24, 2019
That cells attach to titanium has long been known; that "doping" would work has been rejected in the Swedish/Russian Macchiarini scandal with plastic trachea implants killing patients.

There is a (literal) paper trail connecting the N.N. Blokhin National Medical Research Centre of oncology with said surgeon:

https://www.ncbi....29603873 "In vitro assessment of electrospun polyamide-6 scaffolds for esophageal tissue engineering", Macchiarini P. as last author at Kazan Federal University, Kazan, Russia, -> authors at National Research Center "Kurchatov Institute", Moscow, Russia -> authors at N.N. Blokhin Russian Cancer Research Center, Moscow, Russia for "Vascularized biocompatible synthetic tracheal matrix based on ultrafibrous
polymeric material" https://ijpras.co...material , say.

Surgeons hoping for useful methods against evidence it doesn't work, looks like.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more